Narrative updates are currently in beta.

Back to narrative

Update shared on07 Aug 2025

Fair value Decreased 8.52%
AnalystConsensusTarget's Fair Value
€46.16
38.4% undervalued intrinsic discount
14 Aug
€28.42
Loading
1Y
-51.2%
7D
-8.2%

The reduction in SUSS MicroTec's analyst price target primarily reflects lower expectations for both revenue growth and net profit margin, resulting in a revised fair value of €47.04.


What's in the News


  • Dividend of €0.30 per share approved for 2024, a 50% increase year-over-year, totaling €5.7 million payout.
  • Amendments to Articles of Association approved.
  • Launched the XBC300 Gen2 D2W platform, a fully integrated, high-precision hybrid bonding solution developed with SET Corporation SA, targeting advanced 3D IC and high-bandwidth memory applications.

Valuation Changes


Summary of Valuation Changes for SUSS MicroTec

  • The Consensus Analyst Price Target has fallen from €50.46 to €47.04.
  • The Consensus Revenue Growth forecasts for SUSS MicroTec has significantly fallen from 3.1% per annum to 2.6% per annum.
  • The Net Profit Margin for SUSS MicroTec has fallen from 10.65% to 10.02%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.